Epilepsy & Seizures
Article
FDA Approves a Cannabinoid Medicine for Two Forms of Epilepsy
The FDA has approved Epidiolex (...
FDA/CDC
FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
The approval, the first for a marijuana-derived pharmaceutical product, falls in line with the unanimous recommendation of an FDA advisory panel...
From the Journals
Cost of medical care for older adults with epilepsy steadily grows
In the United States, costs during 2003-2014 were nearly twice as high as they were for those without epilepsy.
Medical Education Library
Neurology Board Review: Epilepsy
Conference Coverage
Vaccine-related febrile seizures have zero developmental impact
MALMO, SWEDEN – Aussie study shows Bayley III scores 12-24 months later were identical to those of healthy controls.
Commentary
Epilepsy: Past, Present, and Future
Dr. Thadani is Professor of Neurology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. He...
Conference Coverage
Which Factors Predict Successful Epilepsy Reoperations?
LOS ANGELES—Among patients with intractable focal epilepsy who have failed one or more epilepsy surgeries, reoperation may provide long-term...
Conference Coverage
Long-Term Perampanel Treatment Is Safe and Effective for Adolescents
LOS ANGELES—Treatment for as long as four years with adjunctive perampanel is safe and effective for adolescents with secondarily generalized...
News
FDA Updates
The FDA approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. Aimovig is the first FDA-approved preventive migraine...
Conference Coverage
Guidance coming for mTOR inhibitors in infantile TSC
LOS ANGELES – Survey aimed to describe the wide variation in their off-label use, particularly in infants.
Literature Review
Patients Who Die of SUDEP Largely Live Alone and Die Unwitnessed at Home
Patients whose fatality is attributed to sudden unexpected death in epilepsy (SUDEP) largely live alone; die unwitnessed at home at night, usually...